6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Walgoolan Project Update Grant of Tenement
26m ago	DH Investment Consulting of Raymond James Has Been Named as One of Nation’s Top DC Advisor Teams
26m ago	Early Warning News Release with Respect to the Acquisition of Securities of Resouro Strategic Metals
26m ago	Spartan Metals Closes Private Placement of $5.5 Million
27m ago	United States Lime & Minerals Reports First Quarter 2026 Results and Declares Regular Quarterly Cash Dividend

About

Apellis Pharmaceuticals Inc (NASDAQ:APLS) — investor relations, events, news, and company updates on 6ix.

Latest News

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference

Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting

Financials

Revenue

$1 B

Market Cap

$5.17 B

P/E Ratio

224.50

EPS

0.18

Community Chat

Ask AI